AI May Accelerate Discovery of Drugs for Brain Conditions Like MND US Prioritizes American AI Expansion in Asia Following TrumpXi Meeting Official Trump Postpones AI Executive Order Signing Citing Concerns Over Potential Restrictions Lowes Companies LOW Faces Price Target Reduction Amidst Market Adjustments Shameful Imbalance Youth Benefit Spending Outpaces Job Investment Says Former Minister SBIled Consortium Invites Bids for Essar Group Promoter Guarantees at Rs 200 Crore Reserve Price AKTS Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Pipeline FiscalNote Q1 2026 Earnings EPS Surprise Beats Estimates Despite Stock Decline WHLRD Q2 2024 Earnings Preferred Dividend Coverage Remains Robust Amid Limited Market Visibility RMBS Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Despite Revenue Discrepancy Saga Communications SGA Q1 2026 Earnings Negative EPS of 043 Reflects Persistent Industry Headwinds CBZ Q1 2026 Earnings EPS Surges 124 Above Estimates Driving Strong Profitability Jeffs Brands Ltd Warrant JFBRW Surges 70 Whats Behind the Sharp Move Inspire Medical Systems INSP Dips 2 as Stock Tests Key Support Levels Claritev Corporation CTEV Dips Nearly 8 as Stock Tests Key Support Levels Auddia Inc AUUD Slides 688 as Sellers Test Key Support Near 142 Haleon HLN Holds Steady Near 929 Amid Modest Downside Support and Resistance in Focus AI Wealth Must Benefit Public South Korea Deputy PM Warns Amid Samsung Labor Dispute Retail Investors Gain Direct Access to SpaceX IPO Through Major Brokerage Platforms Wordle 1802 Hints Release Highlights NYT Puzzles Sustained Engagement China Emerges as Primary Rival in Humanoid Robot Race Musk Says Timex Group India Reports INR 800 Cr Revenue Marks 3x Growth in Four Years TechLed Gains Lift SP 500 as Dow Slides on Sector Rotation CRK Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Taylor Devices TAYD Modestly Gains as Shares Hold Above Key Support Level Moelis Company Q1 2026 Earnings EPS Misses Estimates Amid Cautious Advisory Environment Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines EDAP Q4 2025 Earnings EPS Miss Weighs on Shares Amid Operational Headwinds Voyager Therapeutics Q1 2026 Earnings EPS Beats Estimates as Stock Rises Amid Pipeline Progress ICE Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Stock Decline CDP Q1 2026 Earnings EPS Beats Estimates by 2 Stock Slips Modestly GOGO Q1 2026 Earnings EPS Beat Highlights Cost Discipline Stock Edges Lower